Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?
Ontology highlight
ABSTRACT: The cure of a human immunodeficiency virus (HIV)-1-infected patient following allogeneic transplantation from a CCR5-null donor and potential cure of two patients transplanted with CCR5 wild-type hematopoietic stem cells (HSC) have provided renewed optimism that a potential alternative to conventional antiretroviral therapy (ART) is forthcoming. While allogeneic grafts have thus far suggested complete eradication of viral reservoirs, it has yet to be observed following autologous HSC transplantation. Development of curative autologous transplantation strategies would significantly increase the number of treatable patients, eliminating the need for matched donors and reducing the risks of adverse events. Recent studies suggest gene therapy may provide a mechanism for developing curative the
SUBMITTER: Younan P
PROVIDER: S-EPMC3916050 | biostudies-literature | 2014 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA